ARTICLE | Clinical News
Anturol Gel regulatory update
April 11, 2011 7:00 AM UTC
FDA accepted for filing an NDA from Antares for Anturol Gel to treat overactive bladder (OAB). The PDUFA date is Dec. 8. The product is an advanced transdermal delivery (ATD) gel formulation of oxybut...